Table 1 Patient demographics and clinical characteristics.

From: Novel treatment strategy targeting interleukin-6 induced by cancer associated fibroblasts for peritoneal metastasis of gastric cancer

 

IL-6 low

(n = 84)

IL-6 high

(n = 84)

p value

Age (years)

66.7 ± 11.2

66.2 ± 11.6

0.794

Gender, No. (%)

  

0.515

Male

53(63.1)

58(69.0)

 

Female

31(36.9)

26(31.0)

 

Histological type, No. (%)

  

0.537

diffuse

44(52.4)

39(46.4)

 

intestinal

40(47.6)

45(53.6)

 

Lymph node metastasis, No. (%)

  

0.026

Yes

45(53.6)

25(29.8)

 

No

39(46.4)

59(70.2)

 

Stagea, No. (%)

  

0.023

I

32(38.1)

15(17.9)

 

II

18(21.4)

22(26.2)

 

III

25(29.8)

30(35.7)

 

IV

9(10.7)

17(20.2)

 

Distant metastasis, No.

   

Peritoneum

9

14

0.37

Liver

0

2

0.497

Others

0

3

0.62

  1. aTumor stage was classified by the Japanese Classification of Gastric Carcinoma, 3rd English edition.
Back to article page